中华医学杂志（英文版）2019，Vol.132Issue(19)：2378-2379,2.DOI:10.1097/CM9.0000000000000441
Improvement of lymphangioleiomyomatosis following successful tofacitinib treatment for refractory synovitis, acne, pustulosis, hyperostosis, and osteitis syndrome
Improvement of lymphangioleiomyomatosis following successful tofacitinib treatment for refractory synovitis, acne, pustulosis, hyperostosis, and osteitis syndrome
Shuang Liu 1Chen Li 2Ming-Wei Tang 1Wen-Shuai Xu 3Ke-Qi Chen 3Xin Sui 4Xin-Lun Tian 3Kai-Feng Xu3
作者信息
- 1. School of Clinical Medicine, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100005, China
- 2. Department of Traditional Chinese Medicine, Chinese Academy of Medical Sciences & Peking Union Medical College Hospital, Beijing 100730, China
- 3. Department of Respiratory and Critical Care Medicine, Chinese Academy of Medical Sciences & Peking Union Medical College Hospital, Beijing 100730, China
- 4. Department of Radiology, Chinese Academy of Medical Sciences & Peking Union Medical College Hospital, Beijing 100730, China
- 折叠
引用本文复制引用
Shuang Liu,Chen Li,Ming-Wei Tang,Wen-Shuai Xu,Ke-Qi Chen,Xin Sui,Xin-Lun Tian,Kai-Feng Xu..Improvement of lymphangioleiomyomatosis following successful tofacitinib treatment for refractory synovitis, acne, pustulosis, hyperostosis, and osteitis syndrome[J].中华医学杂志（英文版）,2019,132(19):2378-2379,2.
